Platinum Investment Management’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,380,618
Closed -$21.8M 156
2023
Q4
$21.8M Sell
1,380,618
-955,374
-41% -$9.2M 0.88% 25
2023
Q3
$18.1M Buy
2,335,992
+642
+0% +$5.32K 0.71% 26
2023
Q2
$23.2M Sell
2,335,350
-114,552
-5% -$917K 0.8% 29
2023
Q1
$14.2M Buy
2,449,902
+200,191
+9% +$1.73M 0.49% 35
2022
Q4
$17.9M Buy
2,249,711
+365,943
+19% +$1.57M 0.68% 28
2022
Q3
$5.95M Buy
1,883,768
+249,764
+15% +$1.56M 0.25% 47
2022
Q2
$9.36M Buy
1,634,004
+155,271
+11% +$1.21M 0.35% 43
2022
Q1
$10.4M Buy
1,478,733
+662,367
+81% +$10.4M 0.32% 44
2021
Q4
$18.7M Buy
816,366
+29,791
+4% +$769K 0.52% 35
2021
Q3
$23.3M Buy
+786,575
New +$26.7M 0.66% 27

Platinum Investment Management's ICVX Position: Q1 2024 in Review

Platinum Investment Management sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 1,380,618 shares — an estimated $21.8M sold.

Platinum Investment Management first reported a position in ICVX in Q3 2021 and held it in 10 quarters. The position peaked at $23.3M in Q3 2021. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

  • Platinum Investment Management reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Platinum Investment Management sold 1,380,618 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $21.8M.
  • Platinum Investment Management first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
  • Platinum Investment Management's Icosavax, Inc. Common Stock position peaked at $23.3M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Platinum Investment Management's 13F filing for Q1 2024, filed 13 May 2024.